Select Biosciences Ltd

Microfluidics Gives Boost to Protein Crystallization Studies

Date Posted: Friday, January 19, 2007

Print Email to a friend

Proteins produced by cancer cells are among the common targets for anticancer agents, and with efforts in proteomics and cancer genomics, the number of potential protein targets is increasing exponentially.

One of the most powerful approaches to understanding protein function involves determining its three-dimensional structure in atomic detail, but this requires having pure crystals to study. Until recently, protein crystallization has been more art than science, but now, two microfluidic devices have automated the process of crystallizing proteins.

Reporting its work in the Proceedings of the National Academy of Sciences, team of investigators led by Rustem Ismagilov, Ph.D., has developed a nanoliter microfluidic device that can conduct approximately 1,900 crystallization experiments per hour.

The device can vary the chemical conditions within 10 nanoliter plugs of fluid and then screen each plug to determine if the test protein forms high-quality crystals suitable for further study.

Using their device, the researchers crystallized membrane-bound proteins, which experience has shown are among the most difficult to crystallize. The investigators were able to form crystals of a complex bacterial protein and use those crystals to determine the protein’s three-dimensional structure.

The device is designed such that the investigators were able to conduct X-ray diffraction studies on the crystals while they remained in the microfluidic capillaries.

These studies were conducted using a synchrotron X-ray source. The investigators are now in the process of crystallizing as many as 30 membrane-bound proteins as a large-scale test of the device’s capabilities.

Taking a slightly different approach, but still using microfluidics, a research team led by Carl Hansen, Ph.D., at the University of British Columbia developed its own version of a high-throughput crystallization device that varies crystallization parameters in an array-type format.

The device can create up to 1,000 different mixtures of protein and other reagents and then can allow these mixtures to evaporate in a controlled manner, inducing protein crystal formation in those mixtures with the proper chemical conditions. This group published its results in the Journal of the American Chemical Society.

Further Information: http://chemistry.uchicago.edu/fac/ismagilov.shtml



Related news from our archive

Chicago Cancer Genome Project Studies Genetics of 1,000 Tumors
Analyzing the genetics of cancers from different parts of the body may reveal surprising details for treatment and prevention.

Unlikely Genetic Suspect Implicated in Common Brain Defect
Researchers find that the FOXC1 gene contributes to Dandy-Walker malformation, a brain defect that occurs in 1 of every 5,000 births.

Personalized Medicine Can Cut Breast Cancer Risk
The time has come for breast cancer risk assessment, counseling and genetic testing to move from cancer specialists to the realm of primary care, according to a presentation at the AAAS annual meeting.

Metabolic Syndrome Linked to Cold Tolerance
Researchers discover that many of the genetic variations that have enabled human populations to tolerate colder climates may also affect their susceptibility to metabolic syndrome.